RNS, Alzheimer's Grant, July 2005
2:20
http://www.med.umich.edu/opm/newspage/2005/hmalzgrant.htm
U-M Health System receives $10M grant for Alzheimer's disease research
New federal funding will support large memory and aging study, advanced brain scanning, laboratory research and efforts to increase study participation by minorities
Suggested Lead— Alzheimer's disease research at the University of Michigan is getting a $10 million boost: a major grant that will fund a broad array of efforts aimed at finding and fighting the causes of the disease and other memory conditions. Here is Andi McDonnell with more information.
The National Institute on Aging, part of the National Institutes of Health, has awarded a five-year grant to U-M's Michigan Alzheimer's Disease Research Center . For the last 16 years, the center has been the only federal Alzheimer's disease center in Michigan ; it is currently one of only 33 nationwide.
Dr. Sid Gilman, (M.D., F.R.C.P.), the William Herdman Professor of neurology at the U-M Medical School and director of the Michigan Alzheimer's Disease Research Center tells us. . . .
“The University of Michigan will be funded for 5 years by the National Institutes of Health, and specifically by the National Institute on Aging, for its Alzheimer's Disease Research Center. This will be a 5-year grant from the federal government with a total of about 10 million dollars over the 5 years. This will give us funding for our cores, which are groups of investigators who carry out our clinical evaluation for clinical core to evaluate subjects to determine with kind of dementia they have and enroll those who are interested in research.”
The new money will continue to fund the center's Memory and Aging Project which is a long-term study on memory, aging and dementia. Vital information gathered from this study over the last 15 years has allowed researchers to gain new insights into Alzheimer's disease and related disorders.
Gilman is hopeful . . .
“Thanks to these kinds of research efforts, I do see a time in the not so distant future when we will be able to treat this disease hopefully decrease the rate at which it progresses. Hopefully, in the best situation, stop the progression and maybe eventually treat the disorder before it gets started in people who are at high risk for the disease. That's the ultimate aim, to provide a safe treatment in advance of the beginning of the dementia.”
About 4.5 million Americans have Alzheimer's disease — a number that's expected to rise to 10 million in the next 25 years. That prediction creates a critical need for more research on all forms of dementia.
Andi McDonnell, U-M Health System News |
Additional
PRMC Info
